Barclays analyst Adam Seiden raised the firm’s price target on Arcosa (ACA) to $140 from $115 and keeps an Overweight rating on the shares. The firm views the company’s Q1 report as strong. Arcosa is seeing secular growth in utilities, improving profitability in aggregates, and “disciplined” capital allocation, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACA: